[Federal Register Volume 66, Number 10 (Tuesday, January 16, 2001)]
[Notices]
[Pages 3618-3619]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 01-1125]


=======================================================================
-----------------------------------------------------------------------

NATIONAL AERONAUTICS AND SPACE ADINISTRATION

[Notice 01-004]


Notice of Prospective Patent License

AGENCY: National Aeronautics and Space Administration.

ACTION: Notice of prospective patent license.

-----------------------------------------------------------------------

SUMMARY: NASA hereby gives notice that CJAB Associates, LLP, of 
Houston, TX, has applied for a partially exclusive license to practice 
the inventions described and claimed in U.S. Patent No. 5,153,132, 
entitled ``Three-Dimensional Co-Culture Process;'' U.S. Patent No. 
5,153,133, entitled ``Method for Culturing Mammalian Cells in a 
Horizontally Rotated Bioreactor;'' U.S. Patent No. 5,155,034, entitled 
``Three-Dimensional Cell to Tissue Assembly Process;'' U.S. Patent No. 
5,155,035, entitled ``Method for Culturing Mammalian Cells in a 
Perfused Bioreactor;'' U.S. Patent No. 5,308,764, entitled ``Multi-
Cellular Three Dimensional Living Mammalian Tissue;'' U.S. Patent No. 
5,496,722, entitled ``Method for Producing Non-Neoplastic, 3-
Dimensional Mammalian Tissue and Cell Aggregates under

[[Page 3619]]

Microgravity Culture Conditions and the Products Produced Thereby;'' 
U.S. Patent No. 5,627,021, entitled``Multi-Cellular, Three-Dimensional 
Living Mammalian Tissue;'' U.S.Patent No. 5,846,807, entitled ``Media 
Compositions for Three-Dimensional Mammalian Tissue Growth Under 
Microgravity Culture Conditions;'' U.S. Patent No. 5,858,783, entitled 
``Production of Normal Mammalian Organ Culture Using a Medium 
Containing Mem-Alpha, Leibovitz L-15, Glucose Galactose Fructose;'' 
U.S. Patent No. 5,851,816, entitled ``Cultured High-Fidelity Three 
Dimensional Human Urogenital Tract Carcinomas and Process;'' and U.S. 
Patent No. 6,117,674, entitled ``Horizontal Rotating-Wall Vessel 
Propagation in Vitro Human Tissue Models.'' Each of the above U.S. 
Patents is assigned to the United States of America as represented by 
the Administrator of the National Aeronautics and Space Administration. 
Written objections to the prospective grant of a license should be sent 
to the Johnson Space Center.

DATES: Responses to this notice must be received by March 19, 2001.

FOR FURTHER INFORMATION CONTACT: James Cate, Patent Attorney, NASA 
Johnson Space Center, Mail Stop HA, Houston, TX 77058-8452; telephone 
(281) 483-1001.

    Dated: January 9, 2001.
Edward A. Frankle,
General Counsel.
[FR Doc. 01-1125 Filed 1-12-01; 8:45 am]
BILLING CODE 7510-01-U